Abstract
A 48-year-old woman who had been receiving long-term interferon-β for 8 years for multiple sclerosis developed drug-induced World Health Organization group I pulmonary arterial hypertension. Triple therapy for pulmonary arterial hypertension and suspension of interferon-β led to improvement from a high-risk to low-risk state and improvement in exercise hemodynamics, including vascular distensibility, and right ventricle–pulmonary artery coupling. (Level of Difficulty: Advanced.)
Original language | English (US) |
---|---|
Pages (from-to) | 1038-1043 |
Number of pages | 6 |
Journal | JACC: Case Reports |
Volume | 3 |
Issue number | 7 |
DOIs | |
State | Published - Jul 7 2021 |
Externally published | Yes |
Keywords
- exercise
- pulmonary hypertension
- right ventricle
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine